Skip to content

Menu

RESET-RA Study
Insights
Press Releases

SCIENCE
THERAPY
COMPANY
CAREERS

Menu

Home
Science
Therapy
Company
Insights
- Press Releases
Careers
Contact
RESET-RA Study

Revolutionizing how autoimmune diseases are treated

Scientific publications

January 19, 2023

SetPoint Medical Announces $80M Preferred Stock Financing to Advance Company’s Novel Treatment for Autoimmune Diseases

January 19, 2023

SetPoint Medical Announces Expanded $65M Credit Facility to Support Development of the Company’s Novel Platform for Rheumatoid Arthritis

December 26, 2022

IEEE Spectrum – A New Treatment for Arthritis: Vagus-Nerve Stimulation

December 9, 2022

New Scientist – Stimulating the vagus nerve may reduce symptoms of multiple sclerosis

October 10, 2022

First Patient Enrolled in Stage 2 of Pivotal Study of SetPoint Medical’s Pioneering Technology for the Treatment of Rheumatoid Arthritis

September 13, 2022

SetPoint Medical Announces FDA Approval for Continuation of the RESET-RA Pivotal Study

July 22, 2022

WSJ – Electricity Is the New Medical Miracle

January 27, 2022

ABC News – New technology could signal the future of medicine

November 3, 2021

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

CAUTION – Investigational device. Limited by United States law to investigational use.

designElement

© 2023 SetPoint Medical is a registered trademark of SetPoint Medical Corporation in the United States and other countries. By using this website you agree to our Privacy Policy.

DISCLAIMER:

The patient experience shared in this video represents a unique individual experience and does not provide any indication, guide, warranty or guarantee as to the response other people may have to these and related therapies. Responses can and do vary; the response other individuals have could be different, including no response at all. The SetPoint Medical device is an investigational device. Its use is limited by United States law to investigational use. It is not approved for commercial use.